Scientists at Group Health Research Institute (GHRI) have a rare advantage: We work within a system that provides both care and coverage. With a 360-degree view of people’s everyday health experience over time, we discover what works best to serve Group Health’s mission: Better health.
We collaborate closely with Group Health’s medical staff and other providers—gaining from their perspectives on practical approaches to health care’s toughest problems. Together, we create a learning health care system—a place where research strengthens practice and practice strengthen research.
Our faculty members work on interdisciplinary research teams, conducting about 300 studies at any given time. We collaborate with affiliate researchers and others from leading academic institutions and health systems. Our clinical associates help facilitate work within Group Health's own care-delivery system and health plan.
We share our findings freely in the public domain, so that health care organizations everywhere can use our research to serve the public good.
See our GHRI researcher directory
Most of our support comes from federal agencies, such as the National Institutes of Health. We also contract with biomedical companies and receive grants from private foundations, including the Group Health Foundation. About 5 percent of our budget comes from Group Health.
See our list of funders.
Gharib SA, Loth DW, Soler Artigas M, Birkland TP, Wilk JB, Wain LV, Brody J, Obeidat M, Hancock DB, Tang W, Rawal R, Boezen HM, Imboden M, Huffman JE, Lahousse L, Alves AC, Manichaikul A, Hui J, Morrison AC, Ramasamy A, Smith AV, Gudnason V, Surakka I, Vitart V, Evans DM, Strachan DP, Deary IJ, Hofman A, Gläser S, Wilson JF, North KE, Zhao JH, Heckbert SR, Jarvis DL, Probst-Hensch N, Schulz H, Barr RG, Jarvelin MR, O'Connor GT, Kähönen M, Cassano PA, Hysi PG, Dupuis J, Hayward C, Psaty BM, Hall IP, Parks WC, Tobin MD, London SJ; CHARGE Consortium; SpiroMeta Consortium. Integrative pathway genomics of lung function and airflow obstruction. Hum Mol Genet. 2015 Sep 22. pii: ddv378. [Epub ahead of print]. PubMed
Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buist DS, Anderson ML. Aspirin for the prevention of cancer incidence and mortality: systematic evidence reviews for the U.S. Preventive Services Task Force [Internet]. Available from http://www.uspreventiveservicestaskforce.org/Page/Document/draft-evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer.
GHRI oversees all research conducted at Group Health, ensuring that all studies involving Group Health members are aligned with the organization’s primary mission: to improve health. Researchers from outside Group Health can learn more about our processes for collaborating with GHRI faculty members.